Autolus Therapeutics PLC reports results for the quarter ended in September - Earnings Summary

Autolus Therapeutics

03/11/2021 14:07

* Autolus Therapeutics PLC  AUTL.OQ  reported a quarterly
adjusted loss of 47 cents​​ per share for the quarter ended in
September. The mean expectation of nine analysts for the quarter
was for a loss of 51 cents per share.
* Revenue fell 65.3% to $236.00 thousand from a year ago; 
analysts expected $248.33 thousand. 
* Autolus Therapeutics PLC's reported EPS for the quarter was a
loss of 47 cents​.
* The mean earnings estimate of analysts had risen by about 0.7%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Autolus Therapeutics PLC shares had fallen by 15.4% this
quarter and lost 38.0% so far this year.
* The company reported a quarterly loss of $33.99 million.
* Wall Street's median 12-month price target for Autolus
Therapeutics PLC is $13.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 8 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 3 at 02:07 p.m.
 ​All figures in US dollars unless otherwise stated